
Ozempic and Other Weight-Loss Drugs Bear Heavy Costs and Questions for Seniors
Limited data on adults age 60 and older raise questions on whether high-priced weight-loss drugs will really help with lowering rates of chronic illness and disability
Judith Graham, a contributing columnist, writes the "Navigating Aging" column for KFF Health News.
Limited data on adults age 60 and older raise questions on whether high-priced weight-loss drugs will really help with lowering rates of chronic illness and disability
Experts are more concerned about a lack of activity in older adults who are somewhat overweight than about weight loss
Outcomes vary greatly depending on age and other factors, a pulmonologist explains
More of us are getting at least a dozen good, happy years after 65
SuperAgers report strong social relationships
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account